'For
the quarter ending Sept 2023, standalone Net sales (including other operating income) of Abbott India has increased 8.31% to Rs 1,494.14 crore compared to quarter ended Sept 2022. Operating profit margin has jumped from 24.89% to 25.49%, leading to 10.95% rise in operating profit to Rs 380.88 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 9.88% to 9.61%. Purchase of finished goods cost fell from 45.01% to 43.82%. Employee cost decreased from 10.75% to 9.78%. Other expenses rose from 9.67% to 10.70%. Other income up 65.55% to Rs 55.51 crore. PBIDT rose 15.81% to Rs 436.39 crore. Provision for interest fell 21.16% to Rs 3.13 crore. Loan funds declined from Rs 128.86 crore as of 30 September 2022 to Rs 91.54 crore as of 30 September 2023. Inventories declined from Rs 732.14 crore as of 30 September 2022 to Rs 512.39...
Pleaselogin & subscribe to view the full report.
More Reports
-
Sales up 10.26%, while PAT decreased by 2.44%.
-
-
OP up 46.05% and NP up 74.12%
-
(08-Nov-2024)
Sanofi India
|
|